Plasm Metabolomics Study in Pulmonary Metastatic Carcinoma

Table 2

The main metabolites in the comparisons of the pulmonary metastases with the other pulmonary nodule groups.

	Metabolites	Fold change	VIP	Value	AUC of ROC	Critical point	Sensitivity	Specificity
PMC vs. BPN	Tyrosine	1.67	1.39	8.26E−5	0.852	1.71	0.938	0.719
	Indoleacrylic acid	1.76	1.40	3.57E−5	0.869	3.89	0.938	0.844
	LysoPC (16 : 0)	2.43	1.95	1.68E-4	0.836	0.53	0.938	0.687
PMC vs. PLC	Octanoylcarnitine	0.25	1.65	2.71E−9	0.973	6.51	0.888	0.938
	Retinol	0.08	2.25	8.53E−10	0.988	0.99	1.000	0.938
	Decanoylcarnitine	0.21	1.81	9.39E−9	0.956	3.01	0.875	1.000